Cantor Fitzgerald Upgrades HCA Healthcare, Inc.’s (HCA) Price Target, Citing Strategic Strengths

Cantor Fitzgerald elevated HCA Healthcare, Inc.’s (NYSE:HCA) price target to $444 from $405 on May 21, 2025, reaffirming an Overweight rating. The adjustment arises from to analyst’s confidence in the healthcare giant’s operational resilience and growth trajectory and reflects a 16% potential upside from the stock’s current closing price of $381.81.

Cantor Fitzgerald upgrades HCA Healthcare, Inc.’s price target to $444, Citing Strategic Strengths

A team of healthcare professionals in lab coats and masks meeting at a hospital ward.

HCA Healthcare, Inc. (NYSE:HCA), headquartered in Tennessee, is a leading American for-profit company, providing healthcare services through its 186 hospitals and approximately 2,400 care sites in 20 states and the United Kingdom.

The company holds a dominant position in the market, supported by its $92.72 billion market capitalization. According to Cantor Fitzgerald’s lead analysts, Sarah James, HCA Healthcare, Inc. (NYSE:HCA) demonstrated resilient performance across its service lines and significantly recovered from a $250 million EBITDA downturn in late 2024, attributed to hurricane-related disruptions.

With 85% of the patient volumes derived from these locations, the company aims to elevate the care sites per hospital from 13 to 20. HCA Healthcare, Inc. (NYSE:HCA) also has plans to cover the rural emergency services by making additional investments in transportation acquisitions like ambulance and helicopter fleets, and similar healthcare accessibilities.

Notably, the stock experienced a dip in pre-market trading despite better-than-expected Q1 2025 results, including a 20% year-over-year growth in EPS. However, pointing to strategic site expansions and geographic reach initiatives, Cantor Fitzgerald anticipates a long-term value from HCA Healthcare, Inc. (NYSE:HCA).

While we acknowledge the potential of HCA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HCA and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds

Disclosure: None.